Teragen Bio Relocates Headquarters to Pangyo Technovalley View original image


[Asia Economy Reporter Cho Hyun-ui] Theragen Bio announced on the 1st that it has relocated its headquarters to Korea Bio Park in Pangyo Technovalley, Seongnam-si, Gyeonggi-do, to expand its research and development (R&D) capabilities.


Theragen Bio plans to establish advanced clinical genomics testing and analysis facilities, as well as genome-based cancer vaccine and biomarker development facilities at the new headquarters.


About 30 bio companies, including the Korea Bio Association, are located in Korea Bio Park.


Until now, Theragen Bio's headquarters were located at the Next-Generation Convergence Technology Research Institute in Gwanggyo Technovalley, Suwon-si, Gyeonggi-do. It will continue to use that location as a research center for personal genome services and healthcare.



Hwang Tae-soon, CEO of Theragen Bio, said, "With the relocation of our headquarters, all employees will strive with a more challenging and creative attitude to become a world-class genome-based personalized medicine solution company."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing